[go: up one dir, main page]

CN1278166A - 局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物 - Google Patents

局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物 Download PDF

Info

Publication number
CN1278166A
CN1278166A CN98810770A CN98810770A CN1278166A CN 1278166 A CN1278166 A CN 1278166A CN 98810770 A CN98810770 A CN 98810770A CN 98810770 A CN98810770 A CN 98810770A CN 1278166 A CN1278166 A CN 1278166A
Authority
CN
China
Prior art keywords
methyl
acetamide
cyclohexyl
pyrrolidinyl
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98810770A
Other languages
English (en)
Chinese (zh)
Inventor
A·I·拜恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardiome Pharma Corp
Original Assignee
Nortran Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nortran Pharmaceuticals Inc filed Critical Nortran Pharmaceuticals Inc
Publication of CN1278166A publication Critical patent/CN1278166A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN98810770A 1997-09-26 1998-09-25 局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物 Pending CN1278166A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6015497P 1997-09-26 1997-09-26
US60/060,154 1997-09-26

Publications (1)

Publication Number Publication Date
CN1278166A true CN1278166A (zh) 2000-12-27

Family

ID=22027715

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98810770A Pending CN1278166A (zh) 1997-09-26 1998-09-25 局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物

Country Status (5)

Country Link
CN (1) CN1278166A (pt)
AU (1) AU9248698A (pt)
BR (1) BR9814048A (pt)
MX (1) MXPA00002969A (pt)
WO (1) WO1999016431A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1422217A3 (en) 1998-04-01 2004-06-16 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
PL227937B1 (pl) 2003-05-02 2018-01-31 Cardiome Pharma Corp Sposób wytwarzania związku typu eteru aminocykloheksylowego, związek typu eteru aminocykloheksylowego, jego kompozycja, sposób modulowania aktywności kanałów jonowych, oraz zastosowanie związku typu eteru aminocykloheksylowego do wytwarzania leku
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
MXPA06011419A (es) 2004-04-01 2007-04-20 Cardiome Pharma Corp Profarmacos de compuestos moduladores de canales ionicos y usos de los mismos.
EP1868598B1 (en) 2004-11-08 2014-04-23 Cardiome Pharma Corp. A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
US10160727B2 (en) 2014-08-06 2018-12-25 Shionogi & Co., Ltd. Heterocycle and carbocycle derivatives having TrkA inhibitory activity
EP3330256B1 (en) 2015-07-07 2021-06-16 Shionogi & Co., Ltd. HETEROCYCLIC DERIVATIVE HAVING TrkA-INHIBITING ACTIVITY
EP3412663B1 (en) 2016-02-04 2022-09-07 Shionogi & Co., Ltd. Nitrogen-containing heterocycle and carbocycle derivatives having trka inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4212878A (en) * 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
AT376669B (de) * 1982-11-26 1984-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thienylessigsaeureamid-derivate und pharmazeutisch vertraeglicher saeureadditionssalze davon
US5506257A (en) * 1992-03-26 1996-04-09 University Of British Columbia Aminocyclohexylamides for antiarrhythmic and anaesthetic uses

Also Published As

Publication number Publication date
WO1999016431A1 (en) 1999-04-08
AU9248698A (en) 1999-04-23
MXPA00002969A (es) 2002-06-21
BR9814048A (pt) 2000-10-03

Similar Documents

Publication Publication Date Title
JP5186219B2 (ja) 置換アリールアミン化合物および5−ht6調節因子としてのその使用
CN1278166A (zh) 局部麻醉或抗心律不齐同时产生止痛的氨基环己酰胺的对映体混合物
US5506257A (en) Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
EP2867219B1 (en) Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN1184475A (zh) 具有mdr活性的四氢化萘化合物
AU668932B2 (en) Method of blocking sodium channels or neuronal tissue
HK1000684B (en) Aminocyclohexylamides for antiarrhythmic and anaesthetic uses
CN102134245A (zh) 四氢异喹啉类化合物及其制备方法和用途
EP0068998B1 (fr) Aryl-1 aminométhyl-2 cyclopropanes carboxylates (Z), leur préparation et leur application en tant que médicaments utiles dans le traitement d'algies diverses
PT100415B (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
PT95735B (pt) Processo para a preparacao de morfolinois e de composicoes farmaceuticas que os contem
CN101541780B (zh) 贝特羧酸酯类化合物及其制备方法和用途
JPS6214545B2 (pt)
CN101203500B (zh) 取代的芳胺化合物和它们作为5-ht6调节剂的用途
EP0390762A1 (en) New bronchospasmolytic compounds and process for their preparation
EP0050072A1 (fr) Nouvelles cyclopropylméthyl pipérazines, leur procédé de préparation et leur application en thérapeutique
CN1270163A (zh) 3-氨基-3-芳基丙-1-醇衍生物、其制备及用途
CN1921855A (zh) 用于选择性增强心房收缩力以及治疗心功能不全的kv1.5-阻滞剂
CN1775762A (zh) 川芎嗪酰基哌嗪衍生物、制备方法和药物组合物与应用
JPS6119639B2 (pt)
EP0171912A1 (en) Pyrrolizidine compounds, methods for their production, and their uses
CN1293193A (zh) 哌啶基氨基甲基三氟甲基环醚类化合物的制备方法
CN1411379A (zh) 心律失常的预防剂或药物
BE637049A (pt)
JPH0331711B2 (pt)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication